These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 1695227

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Sialyl Lewis(x) antigen as defined by monoclonal antibody AM-3 is a marker of dysplasia in the colonic adenoma-carcinoma sequence.
    Hanisch FG, Hanski C, Hasegawa A.
    Cancer Res; 1992 Jun 01; 52(11):3138-44. PubMed ID: 1350509
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Increased number of accessible sugar epitopes defined with monoclonal antibody AM-3 on colonic mucins is associated with malignant transformation of colonic mucosa.
    Hanski C, Sheehan J, Kiehntopf M, Stolze B, Stein H, Riecken EO.
    Cancer Res; 1991 Oct 01; 51(19):5342-7. PubMed ID: 1717148
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Immunoreactivity of Lewis blood group and mucin peptide core antigens: correlations with grade of dysplasia and malignant transformation in the colorectal adenoma-carcinoma sequence.
    Baldus SE, Hanisch FG, Pütz C, Flucke U, Mönig SP, Schneider PM, Thiele J, Hölscher AH, Dienes HP.
    Histol Histopathol; 2002 Jan 01; 17(1):191-8. PubMed ID: 11813869
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Expression of alpha-3/4-monofucosylated polylactosaminoglycan epitope, as defined by monoclonal antibody FW6, is a marker of the colorectal adenoma-carcinoma sequence.
    Baldus SE, Vierbuchen M, Hanisch FG, Schwonzen M, Fischer R.
    Cancer; 1995 Sep 15; 76(6):954-60. PubMed ID: 8625220
    [Abstract] [Full Text] [Related]

  • 11. Colonic mucin-carbohydrate components in colorectal tumors and their possible relationship to MUC2, p53 and DCC immunoreactivities.
    Hara A, Saegusa M, Mitomi H, Kurihara M, Ishihara K, Hotta K, Okayasu I.
    Pathol Res Pract; 2000 Sep 15; 196(3):159-66. PubMed ID: 10729920
    [Abstract] [Full Text] [Related]

  • 12. Oncofetal mucin M1 epitope family: characterization and expression during colonic carcinogenesis.
    Bara J, Gautier R, Mouradian P, Decaens C, Daher N.
    Int J Cancer; 1991 Jan 21; 47(2):304-10. PubMed ID: 1988372
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Monoclonal antibody against human colonic sulfomucin: immunochemical detection of its binding sites in colonic mucosa, colorectal primary carcinoma, and metastases.
    Yamori T, Ota DM, Cleary KR, Hoff S, Hager LG, Irimura T.
    Cancer Res; 1989 Feb 15; 49(4):887-94. PubMed ID: 2912559
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunohistochemical expression of PCNA and CD34 in colorectal adenomas and carcinomas using specified automated cellular image analysis system: a clinicopathologic study.
    Qasim BJ, Ali HH, Hussein AG.
    Saudi J Gastroenterol; 2012 Feb 15; 18(4):268-76. PubMed ID: 22824771
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.